FSD Pharma Inc.

NASDAQ (USD): FSD Pharma Inc. (HUGE)

Last Price

0.09

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Profile
HUGE

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Zeeshan Saeed Mr. Zeeshan Saeed

Full Time Employees:  17 17

IPO Date:  2018-06-08 2018-06-08

CIK:  0001771885 0001771885

ISIN:  CA35954B4047 CA35954B4047

CUSIP:  35954B206 35954B206

Beta:  0.85 0.85

Last Dividend:  0.00 0.00

Dcf Diff:  0.05 0.05

Dcf:  0.04 0.04

Description

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.

Address

199 Bay Street,
Toronto, ON M5L 1A9, CA

416 854 8884

http://www.fsdpharma.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment